BAD HOMBURG VOR DER HOEHE (dpa-AFX) - Fresenius Medical Care AG & Co. KGaA (FMS) reported first-quarter 2012 net income attributable to shareholders of $370 million, an increase of 68% from last year. The recent quarter's net profit includes a non-taxable investment gain of $127 million related to the acquisition of Liberty Dialysis Holdings, Inc., including its 51% stake in Renal Advantage Partners LLC. Quarterly earnings per share totaled $1.22, a 67% growth from the prior year.
Excluding this investment gain, net income attributable to shareholders of Fresenius Medical Care AG & Co. KGaA rose 10% to $244 million or $0.80 per share.
Net revenue was up 9% year-over-year to $3.25 billion for the recent quarter. For 2012, the company confirmed its sales and earnings outlook, expecting revenue to grow to around $14 billion and net income attributable to shareholders to grow to about $1.14 billion. This exclude the investment gain in the amount of some $127 million in the first quarter of 2012.
Copyright RTT News/dpa-AFX
